SNSE

Sensei Biotherapeutics Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↓ 4/10
  • Momentum↑ 9/10
Sensei Biotherapeutics sales and earnings growth
SNSE Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 19.82%
  • FCF Y/Y↑ 12.07%
Sensei Biotherapeutics gross and profit margin trends
SNSE Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↓ -104.00%
Sensei Biotherapeutics net debt vs free cash flow
SNSE Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -523.8

Sensei Biotherapeutics stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗